Antithrombotic and anticoagulant treatment in the COVID19 era
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=GyvBAe2YwH8
Davide Capodanno, Catania, Italy, Gilles Montalescot, Paris, France, and Dominik Angiolillo, Jacksonville, USA discuss how to manage antithrombotic therapy in patients with COVID-19 undergoing interventional procedures. • • Key take-home messages: • COVID-19 disease is a prothrombotic state • when using antiplatelets, be well aware of drug to drug interaction • most COVID-19 patients will require anticoagulants and LWMH is the preferred drug • when asymptomatic, COVID-19 patients should not be switched between anticoagulants • • More resources on COVID-19 for interventional cardiovascular medicine: • https://www.pcronline.com/Cases-resou...
#############################
